The short answer

Gallbladder problems — gallstones and gallbladder inflammation — are a real but uncommon side effect of GLP-1 medications, and the FDA label says so plainly. In Wegovy's adult weight-loss trials, gallstones occurred in about 1.6% of people on the injection versus 0.7% on placebo. Most people will never have an issue; the point of this article is that seniors should know the warning signs, because a gallbladder attack is often mistaken for ordinary GLP-1 stomach upset — and the two are treated very differently.

What the FDA label actually says

The Wegovy prescribing information carries a specific warning for acute gallbladder disease:

  • Gallstones (cholelithiasis): reported by 1.6% of adults on Wegovy injection vs 0.7% on placebo; 2.5% on Wegovy tablets vs 1% on placebo.
  • Gallbladder inflammation (cholecystitis): 0.6% vs 0.2% on placebo.
  • Notably, the label states the excess risk remained even after accounting for the amount of weight lost — meaning the drug appears to add some risk beyond the weight loss itself.
  • The label instructs that if gallstones are suspected, gallbladder studies and clinical follow-up are indicated — this is a "get checked," not a "wait and see."

Tirzepatide (Zepbound) carries similar gallbladder-related labeling. This is a class-wide consideration, not a one-drug quirk.

Why weight loss itself stacks the deck

Independent of any medication, rapid or substantial weight loss is a classic trigger for gallstones. When you lose weight quickly, the liver pushes extra cholesterol into bile, and a gallbladder that empties less often lets that bile sit and crystallize. Losing more than about 3 pounds a week is the zone traditionally associated with elevated gallstone risk — one more reason pace matters after 65, as we cover in losing weight too fast on a GLP-1.

Age stacks the deck further: gallstones get more common with each decade, and women remain at higher risk than men throughout.

Gallbladder attack vs. ordinary GLP-1 stomach upset

This is the distinction that matters most, because nausea and stomach discomfort are the most common GLP-1 side effects — and most of the time they are just that. A gallbladder attack looks different:

Typical GLP-1 stomach upset: diffuse queasiness, worse after large or greasy meals, improves with smaller meals and time, no fever. Our guide to stopping nausea on GLP-1s covers managing it.

Suspicious for gallbladder trouble:

  • Pain that is localized — upper right belly or center, under the ribs, sometimes radiating to the right shoulder blade
  • Comes in intense episodes ("attacks"), classically 30 minutes to a few hours after a fatty meal
  • Steady, severe pain rather than queasiness — people describe being unable to find a comfortable position
  • Accompanied by fever, chills, vomiting that will not stop, or yellowing of the eyes or skin (jaundice) — these signal a blocked duct or infection

When to act, and how fast

  • Same-week call to your doctor: repeated episodes of right-upper belly pain after meals, even if they pass. Describe the pattern; an ultrasound is the usual first test.
  • Same-day medical attention or the ER: severe pain lasting more than a few hours, pain with fever or chills, persistent vomiting, or any jaundice. A blocked bile duct or infected gallbladder is urgent at any age, and more dangerous after 65.

Do not stop your medication on your own while you wait to be seen — but do tell whoever evaluates you that you take a GLP-1, and how much weight you have lost. Both facts belong in their diagnostic picture. Our full guide to GLP-1 side effects in seniors explains which symptoms warrant which speed of response.

If your gallbladder has to come out

Gallbladder removal (cholecystectomy) is one of the most common operations in older adults, usually done laparoscopically with a short recovery. Two Medicare-specific notes: first, the surgery itself is a covered Part A/B matter, separate from your drug coverage. Second, if it happens, you will face the "GLP-1 before surgery" question — whether to hold a dose and how to prep — which we walk through in stopping GLP-1s before surgery or a colonoscopy. Most people resume their GLP-1 after recovery, and you can live entirely normally without a gallbladder.

If cost is part of what is keeping you from seeing a doctor about symptoms, remember the medication side: eligible seniors pay a flat $50 a month under Medicare's Bridge program — check in 60 seconds with our eligibility quiz.

Data note

Data as of July 2026, verified against the current FDA prescribing information for Wegovy. Individual risk varies — this article helps you recognize symptoms, not diagnose them. Sudden severe abdominal pain deserves prompt medical evaluation. This article is educational and is not medical advice.